L26/P-662 Identification of new genetic variants in patients with idiopathic primary ovarian insufficiency using whole genome sequencing
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von C.T. Güzel und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Which genetic variants contributes to pathogenesis in POI patients? Summary answer A new rare genetic variant of LMNA gene is identified in a POI patient using whole genome sequencing. What is known already Primary ovarian insufficiency (POI) is defined by loss of ovarian function before the age of 40 and often results in infertility. POI is a highly heterogeneous disorder arising from genetic, iatrogenic or environmental factors. While X-chromosome abnormalities and FMR1 premutations are well-established genetic causes, many contributing factors remain unclear. In this study, whole-genome sequencing (WGS) was applied as a comprehensive approach to identify rare genetic variants associated with POI. LMNA encodes Lamin A and C, essential structural components of the nuclear envelope, and has been implicated in multiple disorders, including ovarian failure, supporting a potential role in POI pathogenesis. Study design, size, duration We conducted WGS on 12 patients diagnosed with POI and genomic data was analyzed with a focus on identifying rare variants in known POI-associated genes. One of the identified variants in LMNA gene, was examined in the affected family members of the patient and LMNA expression was determined subsequently in the family and other patients. A comparative LC-MS/MS-based proteomic analysis was applied to identify differentially expressed proteins associated with LMNA knockdown in transfected COV434 cells. Participants/materials, setting, methods WGS was performed on genomic DNA isolated from peripheral blood of 12 patients and variant pathogenicity was evaluated using Varvis® software within a POI-associated gene panel comprising 881 genes. Selected LMNA variant was validated in patient family members by Sanger sequencing. LMNA mRNA expression was assessed in family members and other patients using RT-qPCR. COV434 cells were transfected with LMNA or control siRNA, and differentially expressed proteins were analyzed by comparative LC-MS/MS-based proteomic analysis. Main results and the role of chance A total of 58 rare variants in genes related to POI were detected in 12 patients. Among those variants, one missense variant (c.11C>A (p.(Pro4Gln)) of uncertain significance (VUS) in the LMNA gene (NM_170707.4) detected in one patient was prioritized. This missense variant has been identified before but was not specifically associated with POI yet. Since the patient has a familial POI history, presence of the same variant in the affected mother and sister was confirmed by Sanger sequencing. mRNA expression of the LMNA was reduced in the patient compared to other patients who did not carry the variant. Comparative proteomic analysis revealed significant differential expression of 41 proteins, including 27 upregulated and 14 downregulated, following LMNA knockdown, predominantly involving pathways related to nuclear organization, signal transduction and DNA repair. Limitations, reasons for caution Use of small size of cohort of patients limit the possibility to discover new variants. Analysis of additional family members would have further supported the genetic findings. Additionally, functional analyses are required to evaluate the role of LMNA variant in POI. Wider implications of the findings These findings expand the genetic landscape of primary ovarian insufficiency and highlight LMNA as a potential contributor to ovarian dysfunction. Further studies are needed to validate these findings and explore the clinical implications of identified variants. Trial registration number Yes
Zitieren
APA
Güzel, C., Woral, C., Gottschlich, L., Shen, X., Bender, U., Krivega, M., Obeid, K., Luzarowski, M., Hinderhofer, K., Strowitzki, T., & Rehnitz, J. (2026). L26/P-662 Identification of new genetic variants in patients with idiopathic primary ovarian insufficiency using whole genome sequencing. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.992
Vancouver
Güzel C, Woral C, Gottschlich L, Shen X, Bender U, Krivega M, et al. L26/P-662 Identification of new genetic variants in patients with idiopathic primary ovarian insufficiency using whole genome sequencing. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.992
BibTeX
@article{Gzel2026,
author = {Güzel, C.T. and Woral, C. and Gottschlich, L. and Shen, X. and Bender, U. and Krivega, M. and Obeid, K. and Luzarowski, M. and Hinderhofer, K. and Strowitzki, T. and Rehnitz, J.},
title = {L26/P-662 Identification of new genetic variants in patients with idiopathic primary ovarian insufficiency using whole genome sequencing},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.992}
}
EUVIMED